11月24日 - ** 医疗设备制造商NeuropaceNPCE.O股价盘前上涨2.1%至14.65美元
** 该公司表示，医疗保险将增加对其RNS系统的支付，该系统是一种用于治疗耐药性癫痫的设备。
** 根据2026年的新规定，美国医疗保险与医疗补助服务中心（CMS）将提高向植入或更换RNS系统的医生支付的费用，初次手术提高约43%，更换手术提高45% - NPCE
** CMS还将RNS置换手术移至支付费用最高的门诊类别，将医院报销额提高47%，达到31,526美元 - NPCE
** 公司预计，较高的支付额将支持医疗保险患者使用医生和医院服务的增长。
** 截至上一交易日收盘，股价年累计上涨约 28
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.